These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 266899)

  • 1. Tuberculosis due to Mycobacterium kansasii.
    Elder JL; Edwards FG; Abrahams EW
    Aust N Z J Med; 1977 Feb; 7(1):8-13. PubMed ID: 266899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cavitary lung infection caused by Mycobacterium flavescens.
    Casimir MT; Fainstein V; Papadopolous N
    South Med J; 1982 Feb; 75(2):253-4. PubMed ID: 7058379
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary infection caused by Mycobacterium szulgai.
    Pocza A
    Med J Aust; 1981 Apr; 1(8):419-20. PubMed ID: 7254091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the drug-sensitivity of nontuberculous mycobacteria].
    Makarova MV; Freĭman GE
    Tuberk Biolezni Legkih; 2009; (7):55-8. PubMed ID: 19697858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
    Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
    Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary disease due to Mycobacterium massiliense.
    Mitra S; Tapadar SR; Banerjee D; Bhattacharjee S; Dey S; Kundu S
    Indian J Chest Dis Allied Sci; 2012; 54(1):53-7. PubMed ID: 22779125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
    Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
    Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary infection caused by atypical mycobacteria: a report of 24 cases in Thailand.
    Sriyabhaya N; Wongwatana S
    Rev Infect Dis; 1981; 3(5):1085-9. PubMed ID: 7339809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium kansasii osteomyelitis of the scaphoid.
    Minkin BI; Mills CL; Bullock DW; Burke FD
    J Hand Surg Am; 1987 Nov; 12(6):1092-4. PubMed ID: 3693845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary disease caused by Mycobacterium asiaticum.
    Taylor LQ; Williams AJ; Santiago S
    Tubercle; 1990 Dec; 71(4):303-5. PubMed ID: 2267684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampin-resistant Mycobacterium kansasii.
    Wallace RJ; Dunbar D; Brown BA; Onyi G; Dunlap R; Ahn CH; Murphy DT
    Clin Infect Dis; 1994 May; 18(5):736-43. PubMed ID: 8075262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontuberculous mycobacteria in the HIV infected patient.
    Jones D; Havlir DV
    Clin Chest Med; 2002 Sep; 23(3):665-74. PubMed ID: 12371002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary infection with mycobacterium xenopi: review of treatment and response.
    Banks J; Hunter AM; Campbell IA; Jenkins PA; Smith AP
    Thorax; 1984 May; 39(5):376-82. PubMed ID: 6740540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections].
    Rowińska-Zakrzewska E; Słupek A; Graczyk J; Zwolska-Kwiek Z; Augustynowicz-Kopeć E; Stambrowska A; Byszewska D; Latoś E; Pilarska A; Andrzejczyk Z
    Pneumonol Alergol Pol; 1992; 60(9-10):81-8. PubMed ID: 1338003
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term results of medical treatment in Mycobacterium intracellulare infection.
    Dutt AK; Stead WW
    Am J Med; 1979 Sep; 67(3):449-53. PubMed ID: 474589
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary disease due to atypical mycobacteria: a retrospective study from South India.
    Ramakrishnan CV
    Rev Infect Dis; 1981; 3(5):1090-2. PubMed ID: 7339810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.